Alnylam Pharmaceuticals, Inc. ALNY
$228.65
+0.67%
at last close
Analyst Consensus
- Consensus Rating
- Buy (18 Buy · 4 Hold · 0 Sell)
- Average Price Target
- $394.59
- Implied Upside
- +72.6%
- Price Target Range
- $256.00 – $566.00
- Analysts (12 mo)
- 22
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-14 | Wells FargoDerek Archila |
Maintains | Equal-weight | $316 → $256 |
| 2026-08-04 | Truist SecuritiesDanielle Brill |
Maintains | Buy | $410 → $315 |
| 2026-08-04 | HC Wainwright & Co.Patrick R. Trucchio |
Maintains | Buy | $485 → $455 |
| 2026-08-03 | Raymond JamesMartin Auster |
Upgrades | Outperform → Strong buy | $420 |
| 2026-08-03 | CitigroupEric Joseph |
Maintains | Buy | $380 → $340 |
| 2026-08-03 | BarclaysEliana Merle |
Maintains | Overweight | $527 → $450 |
| 2026-07-31 | JP MorganJessica Fye |
Maintains | Overweight | $400 → $375 |
| 2026-07-31 | RBC CapitalLuca Issi |
Maintains | Outperform | $445 → $350 |
| 2026-07-31 | Morgan StanleyMichael Ulz |
Maintains | Equal-weight | $400 → $300 |
| 2026-07-31 | OppenheimerKostas Biliouris |
Maintains | Outperform | $500 → $350 |
| 2026-07-31 | Wells FargoDerek Archila |
Maintains | Equal-weight | $377 → $316 |
| 2026-07-31 | StifelPaul Matteis |
Maintains | Buy | $444 → $318 |
| 2026-07-31 | Chardan CapitalKeay Nakae |
Maintains | Buy | $425 |
| 2026-07-30 | NeedhamJoseph Stringer |
Maintains | Buy | $510 → $357 |
| 2026-07-22 | JP MorganJessica Fye |
Maintains | Overweight | $420 → $400 |
| 2026-07-14 | B of A SecuritiesTazeen Ahmad |
Maintains | Buy | $460 → $410 |
| 2026-07-13 | Truist SecuritiesDanielle Brill |
Maintains | Buy | $505 → $410 |
| 2026-07-13 | HC Wainwright & Co.Patrick R. Trucchio |
Maintains | Buy | $470 → $485 |
| 2026-07-10 | Morgan StanleyMichael Ulz |
Maintains | Equal-weight | $370 → $400 |
| 2026-06-29 | HC Wainwright & Co.Patrick R. Trucchio |
Maintains | Buy | $510 → $470 |
| 2026-06-04 | HC Wainwright & Co.Patrick R. Trucchio |
Reiterates | Buy | $510 |
| 2026-05-19 | CitigroupEric Joseph |
Initiates coverage on | Buy | $380 |
| 2026-05-05 | HC Wainwright & Co.Patrick R. Trucchio |
Reiterates | Buy | $510 |
| 2026-05-01 | RBC CapitalLuca Issi |
Maintains | Outperform | $450 → $445 |
| 2026-05-01 | Wells FargoDerek Archila |
Maintains | Equal-weight | $376 → $377 |
| 2026-04-13 | Truist SecuritiesDanielle Brill |
Maintains | Buy | $515 → $505 |
| 2026-03-25 | Chardan CapitalKeay Nakae |
Maintains | Buy | $425 |
| 2026-03-25 | HC Wainwright & Co.Patrick R. Trucchio |
Reiterates | Buy | $510 |
| 2026-03-16 | JefferiesFaisal Khurshid |
Downgrades | Buy → Hold | $522 → $330 |
| 2026-02-18 | HC Wainwright & Co.Patrick R. Trucchio |
Reiterates | Buy | $510 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $228.65
- Market Cap
- $29.97 billion
- 52-Week Range
- $197.81 – $495.55
- Average Volume
- 2.13 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.